EMA meets pharmaceutical leaders to discuss the future direction of the EU pharmaceutical system

The European Medicines Agency (EMA), together with Heads of Medicines Agencies (HMA), met senior executives from 24 biopharmaceutical companies and 3 major trade associations for innovative human medicines on 17 April 2026 to discuss priorities for the future of the EU pharmaceutical system.